MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with A

Amfetamine + Dexamfetamine

Amfetamine 2.5mg / Dexamfetamine 2.5mg modified-release capsules

No stability information

Stability notes for Amfetamine 2.5mg / Dexamfetamine 2.5mg modified-release capsules

There are no stability notes for this medicine.

Supplier

Adderall XR 5mg capsules (Imported (United States))

Amfetamine 7.5mg / Dexamfetamine 7.5mg modified-release capsules

No stability information

Stability notes for Amfetamine 7.5mg / Dexamfetamine 7.5mg modified-release capsules

There are no stability notes for this medicine.

Supplier

Adderall XR 15mg capsules (Imported (United States))

Amfetamine 10mg / Dexamfetamine 10mg modified-release capsules

No stability information

Stability notes for Amfetamine 10mg / Dexamfetamine 10mg modified-release capsules

There are no stability notes for this medicine.

Supplier

Adderall XR 20mg capsules (Imported (United States))

Amfetamine 12.5mg / Dexamfetamine 12.5mg modified-release capsules

No stability information

Stability notes for Amfetamine 12.5mg / Dexamfetamine 12.5mg modified-release capsules

There are no stability notes for this medicine.

Supplier

Adderall XR 25mg capsules (Imported (United States))

Amfetamine 15mg / Dexamfetamine 15mg modified-release capsules

No stability information

Stability notes for Amfetamine 15mg / Dexamfetamine 15mg modified-release capsules

There are no stability notes for this medicine.

Supplier

Adderall XR 30mg capsules (Imported (United States))

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.